Tilray Brands (NASDAQ: TLRY) Q2 2025 Earnings Call Jan 10, 2025, 8:30 a.m. ET ...

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

Stock futures dipped on Friday as investors evaluated a much hotter-than-expected December jobs report and awaited the ...

Tilray Brands (TLRY) stock falls 8% in premarket after Q2 revenue misses estimates. However, company reaffirms FY25 guidance ...

The upcoming week will see a pick-up in earnings releases after little activity over the past couple holiday-shortened weeks.

Alliance Global Partners lowered the firm’s price target on Tilray (TLRY) to $1.50 from $1.75 and keeps a Neutral rating on the shares.

Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...

Reports Q2 net revenue $211M, consensus $216.33M. Irwin Simon, Chairman and CEO of Tilray (TLRY) Brands, stated, “In our fiscal second quarter, ...

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Alliance Global Partners has recently reiterated Tilray Brands Inc (TLRY) stock to Neutral rating, as announced on April 5, 2024, according to Finviz. Earlier, on November 2, 2022 ...

Tilray (TLRY) to announce Q2 earnings on January 10th, with expected revenue growth and recent stock decline compared to S&P 500.

We recently compiled a list of the 10 Best Pot Stocks To Invest In According to Analysts. In this article, we are going to ...